Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
La Radiologia Medica|September 8, 2016
Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapyMarco Tampellini, Dario Gned, Chiara Baratelli, et al.
Anticancer Research|December 13, 2005
Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patientsAlfredo Berruti, Alessandra Mosca, Raffaella Bitossi, et al.
Anticancer Research|November 27, 2008
Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patientsRaffaella Bitossi, Carla Maria Sculli, Marco Tampellini, et al.
Bone|August 29, 2006
The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor loadDaniele Generali, Alfredo Berruti, Marco Tampellini, et al.
Anticancer Research|November 1, 2016
Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity ReactionsMarco Tampellini, Simone Benedetto, Elena Rubatto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of CancerFabio Efficace, Pasquale F Innominato, Georg Bjarnason, et al.
Chronobiology International|August 24, 2011
Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963)Pasquale F Innominato, Sylvie Giacchetti, Thierry Moreau, et al.
International Journal of Cancer|April 11, 2012
Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancerPasquale F Innominato, Sylvie Giacchetti, Georg A Bjarnason, et al.
Urologic Oncology|May 12, 2005
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-upAlfredo Berruti, Enrica Fara, Marcello Tucci, et al.
Breast Cancer Research and Treatment|April 28, 2004
Magnetic resonance imaging in comparison to clinical palpation in assessing the response of breast cancer to epirubicin primary chemotherapyMaria Bodini, Alfredo Berruti, Alberto Bottini, et al.
Pageof 5